Table 5 Top 50 predicted miRNAs associated with prostatic neoplasms based on known associations in HMDD
Rank | miRNA | Evidence | Rank | miRNA | Evidence |
|---|---|---|---|---|---|
1 | hsa-mir-155 | I; II | 26 | hsa-mir-196a-2 | I; II |
2 | hsa-mir-18a | I; II | 27 | hsa-mir-429 | Unconfirmed |
3 | hsa-mir-19a | I; II | 28 | hsa-mir-199b | I; II; III |
4 | hsa-mir-19b-1 | I; II; III | 29 | hsa-mir-181b-2 | I; II; III |
5 | hsa-let-7a-3 | I; II; III | 30 | hsa-mir-150 | I; II |
6 | hsa-let-7a-2 | I; II; III | 31 | hsa-mir-138-2 | II |
7 | hsa-mir-29c | I; II; IV | 32 | hsa-mir-138-1 | II |
8 | hsa-mir-9-1 | I; II | 33 | hsa-mir-125a | I; II; III |
9 | hsa-mir-181a-1 | I; II; III | 34 | hsa-mir-24-1 | I; II; III |
10 | hsa-mir-210 | I; II; III | 35 | hsa-mir-30a | I; II; III |
11 | hsa-mir-7-1 | I; II; IV | 36 | hsa-mir-196a-1 | I; II |
12 | hsa-mir-181a-2 | I; II | 37 | hsa-mir-192 | I |
13 | hsa-mir-9-2 | I; II | 38 | hsa-mir-302b | I; II |
14 | hsa-mir-9-3 | I; II | 39 | hsa-mir-451a | I |
15 | hsa-mir-10b | I; II; III | 40 | hsa-mir-103a-2 | I |
16 | hsa-mir-7-2 | I; II; IV | 41 | hsa-mir-302a | I; II; IV |
17 | hsa-mir-142 | I; II | 42 | hsa-mir-20b | I |
18 | hsa-let-7f-2 | I; II; III | 43 | hsa-mir-18b | I |
19 | hsa-let-7i | I; II | 44 | hsa-mir-10a | I; II; III |
20 | hsa-let-7e | I; II | 45 | hsa-mir-302c | I; II |
21 | hsa-let-7 g | I; II; III | 46 | hsa-mir-24-2 | I; II; III |
22 | hsa-mir-7-3 | I; II; IV | 47 | hsa-mir-137 | II |
23 | hsa-let-7f-1 | I; II; III | 48 | hsa-mir-206 | I; II |
24 | hsa-mir-218-2 | I; II; III | 49 | hsa-mir-149 | I; II; III |
25 | hsa-mir-19b-2 | I; II; III | 50 | hsa-mir-135a-1 | I; II; IV |